Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

AMPK modulatory activity of olive–tree leaves phenolic compounds: Bioassay-guided isolation on adipocyte model and in silico approach

  • Cecilia Jiménez-Sánchez,

    Affiliations Department of Analytical Chemistry, University of Granada. Granada, Spain, Research and Development of Functional Food Centre (CIDAF), PTS, Granada, Spain

  • Mariló Olivares-Vicente,

    Affiliation Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University (UMH), Elche, Alicante, Spain

  • Celia Rodríguez-Pérez,

    Affiliations Department of Analytical Chemistry, University of Granada. Granada, Spain, Research and Development of Functional Food Centre (CIDAF), PTS, Granada, Spain

  • María Herranz-López,

    Affiliation Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University (UMH), Elche, Alicante, Spain

  • Jesús Lozano-Sánchez,

    Affiliations Department of Analytical Chemistry, University of Granada. Granada, Spain, Research and Development of Functional Food Centre (CIDAF), PTS, Granada, Spain

  • Antonio Segura-Carretero,

    Affiliations Department of Analytical Chemistry, University of Granada. Granada, Spain, Research and Development of Functional Food Centre (CIDAF), PTS, Granada, Spain

  • Alberto Fernández-Gutiérrez,

    Affiliations Department of Analytical Chemistry, University of Granada. Granada, Spain, Research and Development of Functional Food Centre (CIDAF), PTS, Granada, Spain

  • José Antonio Encinar ,

    ‡ These authors are joint senior authors on this work.

    Affiliation Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University (UMH), Elche, Alicante, Spain

  • Vicente Micol

    ‡ These authors are joint senior authors on this work.

    Affiliations Instituto de Biología Molecular y Celular (IBMC), Miguel Hernández University (UMH), Elche, Alicante, Spain, CIBER: CB12/03/30038, Fisiopatología de la Obesidad y la Nutrición, CIBERobn, Instituto de Salud Carlos III (ISCIII), Palma de Mallorca, Spain

AMPK modulatory activity of olive–tree leaves phenolic compounds: Bioassay-guided isolation on adipocyte model and in silico approach

  • Cecilia Jiménez-Sánchez, 
  • Mariló Olivares-Vicente, 
  • Celia Rodríguez-Pérez, 
  • María Herranz-López, 
  • Jesús Lozano-Sánchez, 
  • Antonio Segura-Carretero, 
  • Alberto Fernández-Gutiérrez, 
  • José Antonio Encinar, 
  • Vicente Micol



Olive-tree polyphenols have demonstrated potential for the management of obesity-related pathologies. We aimed to explore the capacity of Olive-tree leaves extract to modulate triglyceride accumulation and AMP-activated protein kinase activity (AMPK) on a hypertrophic adipocyte model.


Intracellular triglycerides and AMPK activity were measured on the hypertrophic 3T3-L1 adipocyte model by AdipoRed and immunofluorescence microscopy, respectively. Reverse phase high performance liquid chromatography coupled to time-of-flight mass detection with electrospray ionization (RP-HPLC-ESI-TOF/MS) was used for the fractionation of the extract and the identification of the compounds. In-silico molecular docking of the AMPK alpha-2, beta and gamma subunits with the identified compounds was performed.


Olive-tree leaves extract decreased the intracellular lipid accumulation through AMPK-dependent mechanisms in hypertrophic adipocytes. Secoiridoids, cinnamic acids, phenylethanoids and phenylpropanoids, flavonoids and lignans were the candidates predicted to account for this effect. Molecular docking revealed that some compounds may be AMPK-gamma modulators. The modulatory effects of compounds over the alpha and beta AMPK subunits appear to be less probable.


Olive-tree leaves polyphenols modulate AMPK activity, which may become a therapeutic aid in the management of obesity-associated disturbances. The natural occurrence of these compounds may have important nutritional implications for the design of functional ingredients.


Obesity is a multifactorial complex disease of global significance. This disease is defined by excess adipose mass and adipose tissue expansion, which occurs through adipocyte hypertrophy and hyperplasia [1]. Importantly, adipocyte size is a major determinant of obesity in adults [2]. Adipose tissue is a key energy storage organ, and adipose endocrine function is critical to the overall energy balance and homeostasis with adipocyte-derived pro- and anti-inflammatory adipokines playing key roles [3]. When the production and secretion of proinflammatory adipokines prevails, systemic inflammation, insulin resistance and obesity-related metabolic disorders arise [4].

Recently, AMP-activated protein kinase (AMPK) has been revealed to be an important regulator of cellular energy homeostasis. AMPK is a sensor of the cellular energy status that directs metabolic adaptation to support cellular growth and survival, restoring energy homeostasis. AMPK is involved in the regulation of carbohydrate and lipid metabolism, resulting in the inhibition of ATP-consuming anabolic pathways, including FA (fatty acid) synthesis, cholesterol and isoprenoid synthesis, hepatic gluconeogenesis and mTOR (mammalian target of rapamycin)-mediated protein translation. In parallel, AMPK activation stimulates ATP production by increasing FA oxidation, muscle glucose transport, mitochondrial biogenesis and caloric intake [5,6]. It also plays a major role in hormonal signaling and is a central node of such signaling pathways. It can regulate the endocrine system, and at the same time, its activity is regulated by a number of hormones and cytokines (adipokines) such as leptin, interleukin-6, resistin, ghrelin, and adiponectin. In addition, it controls the appetite through a neuroendocrine system that makes it a key regulator of energy metabolism at the whole body level [7].

AMPK is activated by phosphorylation at Thr172, which is modulated by the binding of AMP. Although allosteric activation is only caused by AMP, it has recently been found that similar effects on phosphorylation and dephosphorylation can also be produced by ADP [8]. Specifically, AMPK is phosphorylated by upstream kinases. The primary upstream AMPK kinase is the liver kinase B1 (LKB1), a product of a tumor suppressor gene, which provides anti-tumor functions through the direct phosphorylation of AMPK Thr172 in vitro and in vivo [9,10]. Secondly, Calcium/calmodulin-dependent protein kinase 2 (CaMKKβ), triggers the activation of AMPK in response to increases in cell Ca2+ [11]. Increases in the Ca2+ influx usually accompany such processes as the activation of motor proteins and messages of increased energy consumption. Thus, this activation mechanism anticipates ATP deficiency before it has occurred [12]. The classical pathways through which AMPK is activated by upstream kinases or Ca2+ are now becoming well understood, although the understanding of how phosphatases dephosphorylate the protein in Thr172 remains incomplete [13]. Although changes in the AMP, ATP, or Ca2+ levels are triggered by metabolic stresses, recent work suggests that AMPK can also be switched on by numerous plant-derived phenolic compounds [1417]. To date, sufficient evidence has been accumulated to support that phenolic compounds of Olea europaea might be able to activate AMPK pathways in cancer cell lines through the AMPK/mTOR axis [18,19]. These findings led us to postulate that these compounds could also have important implications in metabolic stress-related disorders such as obesity through AMPK-dependent mechanisms.

In this context, we have studied the capacity of an Olive-tree leaves extract to modulate triglyceride accumulation and AMPK activation using the well-established 3T3-L1 adipocyte model. The characterization of the phenolic extract was achieved using RP-HPLC-ESI-TOF/MS, and semi-preparative fractionation was performed to identify putative candidates for the attributed biological activity. A molecular docking approach was utilized to obtain the free energy variation of the molecular structures of the identified compounds on the AMPK alpha-2, beta and gamma subunits to search for direct AMPK interaction. Finally, a correlation between the most active Olive-tree leaves compounds in the cellular model and those bearing lower free energy values is proposed for the rational understanding of AMPK modulation by the extract.

Materials and methods


For the semi-preparative fractionation of the Olive-tree leaves extract, all chemicals were of analytical reagent grade and were used as received. Methanol used for the extraction was purchased from Panreac (Barcelona, Spain). Acetic acid and acetonitrile for semi-preparative HPLC were purchased from Fluka and Sigma-Aldrich (Steinheim, Germany), respectively. Water was purified by a Milli-Q system from Millipore (Bedford, MA, USA). 3T3-L1 mouse embryo fibroblasts were purchased from the American Type Culture Collection (Manassas, VA, USA). Dexamethasone (DEX), 3-isobutyl-1-methylxanthine (IBMX), insulin, penicillin—streptomycin, calf serum, fetal bovine serum (FBS) (both being HyClone), paraformaldehyde solution, and Triton X-100 were obtained from Sigma-Aldrich (Madrid, Spain). Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Gibco (ThermoFisher Scientific, Waltham, MA, USA). Polyvinyldifluoride (PVD) filters, 0.22 μm, were obtained from Millipore (Bedford, MA, USA), and Dulbecco’s phosphate buffered saline (PBS) was obtained from Sigma-Aldrich (St. Louis, MO, USA). The staining AdipoRed Assay Reagent was obtained from Lonza (Walkersville, MD USA).

Preparation of the Olive-tree leaves extract

Olive-tree leaves (Olea europaea) from the ‘Arbequina’ cultivar were used in this study. They were air-dried in the laboratory, and sample extraction was performed as described elsewhere [20]. Briefly, dry leaves (5 g) were crushed and extracted via Ultra—Turrax T18 basic reagent (IKA, Staufen, Germany) using 300 mL of MeOH/H2O (80/20). After solvent evaporation, the extracts were reconstituted with MeOH/H2O (50/50) to achieve a concentration of 50 mg/mL. Three extraction replicates were processed.

Analytical characterization of the Olive-tree leaves extract and isolated fractions

The Olive-tree leaves extract was analytically characterized by RP-HPLC-ESI-TOF/MS, performed in an Agilent 1200-HPLC system (Agilent Technologies, Waldbronn, Germany) of the Series Rapid Resolution equipped with a vacuum degasser, autosampler, a binary pump, and a UV-vis detector. The chromatographic separation was carried out as reported elsewhere [21]. The extract and the fractions were injected at a concentration of 1 mg/mL.

The compounds separated were monitored with a mass-spectrometry detector. MS was performed using a microTOF (Bruker Daltonik, Bremen, Germany), which was equipped with an ESI interface (model G1607A from Agilent Technologies, Palo Alto, CA, USA) operating in the negative-ion mode. The optimum values of the source and transfer parameters were described elsewhere [22]. The accurate mass data for the molecular ions were processed using the software Data Analysis 3.4 (Bruker Daltonik).

Semi-preparative fractionation of the Olive-tree leaves extract

Semi-preparative fractionation of the Olive-tree leaves extract was achieved using a Gilson preparative HPLC system (Gilson, Middleton, WI, USA) equipped with a binary pump (model 331/332), an automated liquid-handling solution (model GX-271), and a UV-Vis detector (model UV-Vis 156). The extract was fractionated at room temperature. A 250 mm x 10 mm i.d., 5 μm Phenomenex RP-C18 column was used to separate the compounds. The mobile phases consisted of acetic acid 0.5% (A) and acetonitrile (B). The following multi-step linear gradient was applied: 0 min, 5% B; 5 min, 15% B; 53 min, 27% B; 54 min, 28% B; 60 min, 100% B; 65 min, 100% B; 70 min, 5% B; 75 min, 5% B. The injection volume was 500 μL and the flow rate used was set at 10 mL/min. The compounds separated were monitored with UV-Vis (240 and 280 nm) and MS, using the time-of-flight mass spectrometer detector microTOF (Bruker Daltonik, Bremen, Germany), as reported in the previous section.

Cell culture and treatment and intracellular lipid quantitation

The 3T3-L1 preadipocyte cell line was cultured and differentiated as described elsewhere [23]. Hypertrophied adipocytes were obtained using high glucose medium containing insulin (4.5 mg/mL) after differentiation [24]. Under these conditions, cells become hypertrophic adipocytes, a cell model characterized by a high level of cytoplasmic lipid accumulation, insulin-resistance, and exacerbated oxidative stress, a situation reasonably similar to that of obese adipose tissue [16,24]. On day 18, cells were treated with the respective extract or fractions, which were dissolved in 10% FBS/high glucose (4.5 mg/mL) DMEM medium with 1 μM insulin and maintained for 48 h. For cell treatments, extract or fractions were reconstituted in cell culture medium plus DMSO at a maximum final concentration of 0.3% v/v after solvent evaporation. The crystal violet assay was performed as reported to dismiss the possible cytotoxic effects of the extract/fractions at the working concentrations [24,25]. Quantification of intracellular lipid droplets in hypertrophic adipocytes was performed as reported [24] using the staining AdipoRed Assay Reagent and the Cytation 3 cell imaging multi-mode microplate reader (Biotek Instruments, Winooski, VT, USA).

Quantification of the AMPK and pAMPK levels

For AMPK and phospho-AMPK (pAMPK) detection, an immunofluorescence assay was carried out. Cells were washed with PBS, fixed for 15 min in 4% paraformaldehyde, permeabilized in 0.25% Triton X-100 for 5 min, and washed with PBS. After blocking in 4% goat serum at room temperature for 1 h, the cells were washed and incubated overnight at 4°C with mouse monoclonal to AMPK alpha 1 + AMPK alpha 2 antibodies (Abcam, Cambridge, UK) or rabbit monoclonal phospho-AMPKα (Thr172) antibodies (Cell Signaling Technology, Danvers, MA, USA). Cells were washed 3 times with PBS and incubated at ambient temperatures for 6 hours with Hoechst staining (2.5 μg/mL) together with each corresponding polyclonal secondary antibody, goat anti-rabbit IgG CF 594, or goat anti-mouse polyvalent immunoglobulins (G,A,M)-FITC, all from Sigma-Aldrich (St. Louis, MO, USA). Cells were washed 3 times with PBS and read with a Cytation 3 cell imaging multi-mode microplate reader (Biotek Instruments, Winooski, VT, USA). AMPK was detected by measuring the fluorescence with excitation at 490 nm and emission at 520 nm for AMPK and with excitation at 590 nm and emission at 620 nm for pAMPK. To ensure that the extracts/fractions were not cytotoxic, the cell count was performed by taking microphotographs of the Hoechst-stained cells at 4x, using the DAPI imaging filter cube.

Molecular docking procedures

To date, several crystal structures of the three AMPKs have been solved and deposited into the Protein Data Bank, many of them with their inhibitors that delimitate their binding site. For AMPK catalytic subunit alpha-2 (UniProt P54646), the following structures have been used as a receptor in the molecular docking experiments for AMPK beta subunit (UniProt Q9Y478): 4CFE, 4CFF, 4ZHX, 5EZV. Finally, for the AMPK gamma subunit (UniProt P54619), several crystal structures were chosen: 2UV4, 2UV5, 2UV6, 2UV7, 4CFE, 4CFF, 4RER, 4REW, and 4ZHX. Prior to initiating the docking procedure, the protein (receptor) and ligand structures should be prepared [26]. A grid with the dimensions of 22 x 22 x 22 points was centered to ensure coverage of the binding site of the structure. AutoDock/Vina was set up on a Microsoft Windows 10 system using configuration files, including the usage of two CPUs and an effectiveness of 20.

Statistical analysis

Values are represented as the mean ± standard deviation (S.D.) of the mean. The values were subjected to statistical analysis (one-way ANOVA, and Dunett’s test for multiple comparisons/non-parametric approaches). The differences were considered to be statistically significant at p < 0.05. All analyses were performed using Graph Pad Prism 6 (GraphPad Software, Inc. La Jolla, CA, USA). *p < 0.05, **p < 0.01 and ***p < 0.001 on the bars indicate statistically significant differences compared to the control, unless otherwise stated. All cellular measurements were derived from three independent experiments. Each experiment was performed in sextuplicate, unless otherwise specified.


Characterization of the Olive-tree leaves extract by RP-HPLC-ESI-TOF

The Olive-tree leaves extract obtained as described in the materials and methods section was characterized using the RP-HPLC-ESI-TOF/MS methodology. The identification was performed by comparing the retention times from the MS data provided by the TOF analyzer and those from the literature (Fig 1).

Fig 1. HPLC-MS characterization of Olive-tree leaves extract.

Base peak chromatogram (BPC) of the Olive-tree leaves extract in the negative ion mode obtained by RP-HPLC-ESI-TOF/MS, in which the peaks are identified by numbers 1–78 according to the elution order.

The chromatographic profile obtained by RP-HPLC-ESI-TOF/MS showed several peaks, of which a total of 78 were tentatively identified. Compound numbers were assigned according to their elution order.

As shown in Table 1, most of the compounds belonged to the phenolic compound classes, specifically to the iridoid (most of them being secoiridoids), phenylethanol derivative, cinnamic acid, phenylpropanoid, coumarin, flavonoid, and lignan subclasses. The chemical structures of the identified compounds are included in S1 Fig.

Table 1. Relevant mass data of the proposed compounds detected in the Olive-tree leaves extract analyzed by RP-HPLC-ESI-TOF/MS.

From left to right: peak number, retention time, calculated m/z, calculated m/z, molecular formula, error (ppm), millisigma value, proposed compound; and reference and matrix in which the proposed compound has been previously described.

The effects of Olea euroapea leaf extract on triglyceride accumulation and AMPK activity modulation in 3T3-L1 hypertrophic adipocytes

Hypertrophic and insulin resistant adipocytes were treated for 48 hours with different concentrations of the crude extract. After 48 h, the quantification of intracellular lipids was measured with the probe AdipoRed. Cells treated with 400, 600, and 800 μg/mL of the extract decreased triglyceride accumulation by 93, 92, and 86%, respectively (Fig 2), but statistically significant differences compared with the non-treated cells maintained in high glucose medium were found only at 800 μg/mL of the extract (p<0.01). Microscopic observation of cells treated with 800 μg/mL of the extract revealed a significant reduction in the intracellular triglyceride accumulation.

Fig 2. Intracellular triglyceride accumulation inhibitory effect of the complete Olive-tree leaves extract in 3T3-L1 hypertrophic adipocytes.

(A) Quantitative assessment of lipid vesicles in hypertrophic adipocytes incubated with 400, 600, or 800 μg/mL of Olive-tree leaves extract and compared to the control in a high glucose medium. Values have been normalized with respect to the control incubated in a high glucose medium. ** p<0.01 indicates significant differences compared to the control. Representative microphotographs for the qualitative assessment of 3T3-L1 lipid droplets: hypertrophic adipocytes differentiated for 22 days, phase contrast (panel B), same cells stained for triglycerides in lipid droplets (green, panel D) and nuclei stained with DAPI to show the localization of nuclear DNA (blue, panel C). Superimposed lipid droplets and cellular nucleus (panel E).

With the aim of unveiling the possible molecular mechanisms of the reduction of intracellular lipid accumulation, we studied the effects of the Olive-tree leaves crude extract on the activation of AMPK through the phosphorylation of Thr172. After 48 hours of treatment with increasing concentrations of the extract, the levels of AMPK and pAMPK at Thr 172 (pAMPK) were quantified by immunofluorescence (Fig 3). No significant changes in the total AMPK protein levels were detected (Fig 3A), while the phosphorylation of the protein showed a dose-response behavior upon the increase of the Olive-tree leaves extract concentration, exhibiting significant differences at 800 μg/mL compared to the high glucose-treated control cells (p<0.05). At this concentration, the Olive-tree leaves extract promoted an important AMPK activation, considering that one observed with the AMPK activator AICAR, an AMP synthetic analog (Fig 3B). Microscopic observation of the treated cells also revealed a significant increase in the fluorescence intensity corresponding to pAMPK levels in cells treated with the complete extract at 800 μg/mL (Fig 3G) compared to the control (Fig 3D).

Fig 3. Olive-tree leaves extract activates AMPK in hypertrophic adipocytes.

Measurement of the total AMPK expression levels (A) and the activation/inhibition rate (%), measured as the ratio pAMPK/AMPK, (B) Immunofluorescence microscopy of hypertrophic adipocytes treated with 400, 600, and 800 μg/mL of the olive-tree leaves extract and incubated in high glucose medium. Values were normalized with respect to the high glucose control. With comparative aims, the positive control 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) has also been included. *p<0.05 indicates significant differences compared to the control incubated in high glucose medium. Representative microphotographs taken with a fluorescence microscope at 20x: control cells incubated in high glucose medium (total AMPK, green fluorescence, C; pAMPK, red fluorescence, D; nuclei, blue fluorescence, E; superimposed image, I) vs. cells incubated with 800 μg/mL of olive-tree leaves extract (total AMPK, F; pAMPK, G; nuclei, H; superimposed image, J).

Bio-assay guided isolation of AMPK modulators derived from the Olive-tree leaves extract by semipreparative liquid chromatography

To delimit the bioactive compounds responsible for the observed AMPK activation of the Olive-tree leaves extract, we developed a semi-preparative HPLC-ESI-TOF/MS methodology to fractionate the extract according to the UV and MS information. Twenty-eight fractions were obtained to be analyzed for AMPK activation (S2 Fig).

To study which individual compounds were responsible for the mentioned AMPK activation/inhibition, fractions were incubated for 48 hours at a concentration of 400 μg/mL. The levels of AMPK and pAMPK were quantified by immunofluorescence as described in the Methods (Fig 4). Some fractions, such as F1, F8 and F11, exhibited increased levels of total AMPK expression, while some others showed a weak but significant decrease in the AMPK expression levels compared to the controls, i.e., F12, F13, F18, F25, F26 and F27, (Fig 4A). In addition, some fractions showed a significant AMPK activation (F3, F4, F11, F12, F13, F18, F25 and F27), whereas others exhibited an AMPK inhibition (F6, F8, F16, F17 and F28) (Fig 4B).

Fig 4. Modulation of AMPK expression and/or activity by Olive-tree leaves fractions.

Measurement of the total AMPK expression levels (A) and the activation/inhibition rate (%), measured as the ratio pAMPK/AMPK (B) of the selected olive-tree leaves extract fractions in 3T3-L1 hypertrophic adipocytes. The modulatory effects on the AMPK expression levels and the effects on the pAMPK/AMPK ratio were quantified by immunofluorescence microscopy at a concentration of 400 μg/mL in cells incubated in high glucose medium. Values are normalized with respect to the high glucose control. With comparative aims, the positive control 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) was also included. *, **, and *** indicate significant differences with respect to the control incubated in high glucose medium (p<0.05, p<0.01, and p<0.001, respectively).

Those fractions showing activation/inhibition capacity or expression level modulation of AMPK compared to the control were analyzed and fully characterized at the analytical scale by RP-HPLC-ESI-TOF/MS, as described in the Methods, to identify the responsible compounds for such an effect (Fig 5). The rest of the isolated fractions were not subjected to subsequent RP-HPLC-TOF/MS analysis.

Fig 5. HPLC-MS characterization of the Olive-tree leaves fractions.

Base peak chromatogram (BPC) of the selected fractions (F1-F28) in negative ion mode obtained by RP-HPLC-ESI-TOF/MS. The resulting peaks are identified with numbers 1–78, according to the order of elution.

Among the fractions showing AMPK activation (Fig 5), fraction 3 contained compounds 15 (oleoside/secologanoside isomer 4), 16 (elenolic acid glucoside/methyloleoside isomer 2), and 17 (p-coumaric acid glucoside), the latter being the most abundant compound. Fraction 4 contained compounds 16, 17, 18, and 20 (unknown); fraction 11 was composed of small quantities of compounds 29 (unknown), 30 (demethyloleuropein), and larger quantities of 32 (hydroxyoleuropein/hydroxyoleuroside isomer 1), 33 (glucosyl rhamnosylquercetin isomer 2), and 34 (luteolin rutinoside isomer 2). Fraction 12 contained compounds 32, 33, 34, 35 (olivil), 36 (verbascoside) as major compounds, along with 37 (luteolin glucoside isomer 1). Fraction 13 contained compounds 36, and 37; fraction 18 contained compounds 44 (oleuropein glucoside/neonuezhenide isomer 5), 48 (luteolin glucoside isomer 2), and 49 (diosmetin glucoside) as the major compounds, along with compound 50 (calceolarioside isomer 1). Fraction 25 contained compounds 59 (oleuropein/oleuroside isomer 4), 60 (unknown), and 61 (unknown). Finally, fraction 27 mostly contained compounds 69 (luteolin) and 72 (unknown) and minor amounts of compounds 64 (unknown), 65 (dimethyl hydroxy octenoyloxi secologanoside isomer 2), 66 (ligstroside isomer 2), 67 (oleuropein methyl ether), 68 (oleuropein/oleuroside isomer 5), 70 (quercetin), 71 (resinoside) and 73 (unknown).

In contrast, some other fractions showed a significant inhibition of AMPK activity (Fig 5) Fraction F6 contained compounds 22 (elenolic acid glucoside/methyloleoside isomer 3), 24 (oleuropein aglycone), and 25 (glucosyl rhamnosyl quercetin -–rutin—isomer), along with minor quantities of compound 19 (unknown). F8 contained mostly compound 27 (phenethyl primeveroside) and also significant amounts of compounds 28 (ethyl-glucopyranosyloxy-oxopropyl-cyclohexaneacetic acid) and 29 (unknown). F16 mostly contained compound 43 (oleuropein glucoside isomer 4) and minor quantities of compounds 40, 42, 44 (oleuropein glucoside/nuezhenide isomers 2, 3, and 5, respectively), and 45 (diosmetin rhamnoside glucoside—diosmin—isomer 1). F17 contained compounds 47 (apigenin glucoside) and 48 (luteolin glucoside isomer 2) and minor quantities of compound 46 (diosmetin rhamnoside glucoside—diosmin—isomer 2). Finally, F28, which drastically decreased the level of AMPK activation through phosphorylation by 30% (p<0.001), contained compounds 73 (unknown), 74 (trihydroxystearic acid), 75 (apigenin), 76 (trihydroxy-octadecenoic acid), 77 (unknown), and 78 (dihydroxyhexadecanoic acid).

Among those fractions showing a potent AMPK activation capacity through phosphorylation, a distinct behavior was observed for the total AMPK expression levels. The total AMPK levels were not significantly altered by fractions 3, and 4, were significantly increased (p<0.001) by fraction 11, and were significantly reduced (p<0.001) by fractions 12, 13, 18, 25 and 27. Most fractions with inhibitory AMPK activity showed no change in the total AMPK expression levels, i.e., fractions 6, 16, 17 and 28. However, fraction 8 exhibited decreased AMPK expression levels compared to the control.

Molecular docking of the identified compounds against AMPK binding sites

The aim of molecular docking is to predict the structure of the ligand-receptor complex using computational methods. In the current study, all known x-ray structures of AMPK alpha, beta and gamma have been docked with the identified compounds of each fraction (see S3 Fig). The Gibbs free energy variation (ΔG) is represented in Fig 6. All solved structures for the different subunits of AMPK have different co-crystallized ligands, which allows us to define the binding sites on which to perform the molecular docking (see S3 Fig). Additionally, we have performed molecular docking with the x-ray crystallographic ligands over its binding sites as a control of the best ΔG in each binding site. All three x-ray ligands of the AMPK gamma subunit present a ΔG ≈ – 6.5 ± 0.5 Kcal/mol when docked over its respective binding sites (PDB: 2UV4, 2UV5, 2UV6, 2UV7, 4CFE, 4CFF, 4RER, 4REW, and 4ZHX). As we can see in Fig 6, when the compounds contained in the Olive-tree leaves fractions bearing biological activity over AMPK (Fig 5) were docked to these three sites of the gamma subunit, the ΔG was less than or equal to the corresponding value for the crystallographic ligands. These results may indicate that these Olive-tree leaves compounds might act as potential ligands for the AMPK gamma subunit.

Fig 6. Comparison of the free energy variation (ΔG) of the Olive-tree leaves phenolic compounds and ligand against the binding sites of the three AMPK subunits obtained by molecular docking.

Comparison of the free energy variation (ΔG) for all the identified compounds (Table 1 and S2 Fig) contained in those fractions showing activation/inhibition capacity of AMPK (Figs 4 and 5), based on molecular docking analysis against all known binding sites of AMPK (S3 Fig).

In contrast, when the same compounds were docked against the AMPK alpha subunit binding site or the AMPK beta subunit regulatory binding site, the ΔG for the Olive-tree leaves compounds exhibited higher values than those shown by the respective x-ray ligands of these binding sites. Only a few compounds showed ΔG values that were relatively close to those observed for the x-ray ligands, i.e., lower than– 8.0 ± 0.5 Kcal/mol. These included compounds 34, 36, 37, 45, 46, 47, 48, 49, 69, 70, 71 and 75 for the AMPK alpha subunit and compounds 34, 45, 46, 47, 50, 69, 70 and 75 for the AMPK beta subunit regulatory binding site.


Plant polyphenols are the most intensively studied natural products, as they are a recognized source of active compounds used to alleviate noncommunicable diseases such as obesity [16,27]. Plant derived polyphenols such as epigallocatechin gallate from green tea, resveratrol from grapes, curcumin from turmeric, quercetin from onion, phenylpropanoids from Lippia citriodora, or anthocyanins/flavonols from Hibiscus sabdariffa [4,16,17,24,28] have demonstrated either the inhibition of adipogenesis or the attenuation of intracellular lipid accumulation in 3T3-L1 adipocytes, a well characterized model of in vitro adipogenesis that becomes hypertrophic and insulin resistant when induced with high-glucose conditions [16,23,24]. Nevertheless, to date, there are no other reports on this ameliorative effect for Olive-tree leaves extracts. Our results suggest that Olive-tree leaves extracts have the potential to reduce lipid accumulation in hypertrophic and insulin resistant adipocytes. AMPK activation by phosphorylation at Thr-172 has also been correlated with a reduced lipid accumulation in the cytoplasm of 3T3-L1 adipocytes by several phenolic extracts [16,24,29], which is in agreement with our results of Olive-tree leaves extracts from using hypertrohic adipocytes.

In this regard, several lines of evidence have indicated a direct link between AMPK and lipid metabolism. It has been reported that AMPK exerts multiple effects that lead to the normalization of lipid metabolism in adipose tissue. It directly phosphorylates acetylCoA carboxylase (ACC), which leads to the inhibition of fatty acid synthesis and the stimulation of fatty acid uptake into mitochondria through malonylCoA decrease [15,30]. It inhibits lipolysis through the phosphorylation of hormone sensitive lipase [31]. It inhibits the synthesis of triglycerides and phospholipids via the inactivation of glycerol phosphate acyl transferase (GPAT), and it downregulates the transcription of lipogenic genes, including those encoding ACC, fatty acid synthase (FAS), and GPAT [32,33]. Although the Olive-tree leaves extract is able to reduce the intracellular lipid accumulation in 3T3-L1 hypertrophic adipocytes through AMPK-dependent mechanisms, more studies will need to be performed to decipher which downstream targets are involved.

The fractionation of the Olive-tree leaves extract through semi-preparative RP-HPLC-ESI-TOF/MS allowed us to delimit the number of possible candidate compounds responsible for the observed activation of AMPK. Specifically, the components that might contribute to this effect in a higher extent belonged to the secoiridoids (isomers of oleoside/secologanoside, elenolic acid glucoside/methyloleoside, demethyloleuropein, hydroxyoleuropein/hydroxyoleuroside, oleuropein glucoside/neonuezhenide, oleuropein/oleuroside isomers, dimethyl hydroxy octenoyloxi secologanoside, ligstroside, oleuropein methyl ether), the cinnamic acids, phenylethanoids and phenylpropanoids (p-coumaric acid glucoside, verbascoside, and calcelarioside isomers), the flavonoids (isomers of glucosyl rhamnosylquercetin—rutin–, luteolin rutinoside, luteolin glucoside, diosmetin glucoside, luteolin, quercetin, resinoside), and the lignans (olivil) subclassess. The fact that fractions 12 and 13 share compounds 36 (verbascoside) and 37 (luteolin glucoside isomer 1) and that the adjacent fraction (14) contained almost exclusively compound 37 and did not exhibit AMPK activation suggests that verbascoside could be the main agent responsible for AMPK activation in these fractions. However, confirmation with the pure standard should be carried out to verify this hypothesis. Moreover, elenolic acid glucoside and -coumaric glucoside, which are both present in fractions 3 and 4, diosmetin glucoside in fraction 18, unknown compounds 61 and 62 in fraction 25 and luteolin and unknown compound 72 in fraction 27, might contribute to the observed AMPK activation in these particular fractions.

It should be highlighted that fractions F11, F12 and F13, which contained verbascoside (F12 and F13), and hydroxyoleuropein, rutin and luteolin rutinoside (F11 and F12) exhibited the maximum level of AMPK activation, and this activation was as potent as that obtained with the AMPK synthetic activator AICAR. In agreement with our results, lemon verbena polyphenolic extract and its major compound verbascoside have recently exhibited the capacity to activate AMPK concomitantly to the peroxisome proliferator-activated receptor gamma (PPAR-gamma)-dependent transcriptional upregulation of adiponectin, the upregulation of PPAR-alpha mRNA expression and the downregulation of the mRNA expression of fatty acid synthase [16].

The molecular mechanism by which these Olive-tree leaves polyphenols exert their activation needs to be elucidated. On the one hand, these compounds may reach upstream AMPK targets such as LKB1 or CaMKKβ kinases, adipokines or ROS-dependent calcium channel activation [10,11,14]. Furthermore, our in silico study also suggests the possibility that some Olive-tree leaves polyphenols may act as direct modulators of AMPK at different binding sites. The binding of AMP to the gamma subunit causes the allosteric activation of AMPK kinase. The binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase [8]. Increased AMPK activity leads to a concomitant increase in the phosphorylation of its downstream targets. In addition to regulation by adenine nucleotides, a number of small molecules have been identified that directly activate AMPK [34]. The kinase domain of the α-subunit and the carbohydrate-binding module of the β-subunit are connected and define a new regulatory binding site (see S3 Fig, panels C and D). Molecular docking of the A-769662 compound, a small activator of AMPK kinase [35] for this regulatory site, presents a ΔG ≈ – 10.72 ± 0.30 Kcal/mol. Several compounds identified by RP-HPLC-TOF/MS show good enough ΔG values to be considered as putative AMPK ligands or regulators, i.e., -10.1 ± 0.8 < ΔG < 8.0 ± 0.2 Kcal/mol. As an example, the compounds demethyloleuropein, 10-hydroxyoleuropein, (7''S)-hydroxyoleuropein, luteolin 7-rutinoside, diosmin, quercetin, etc., satisfy this condition and could, therefore, have a regulatory effect on this binding site, although obviously with less intensity than the activator A-769662. Staurosporine is an ATP-competitive kinase inhibitor that binds to many kinases with a high affinity, though with little selectivity. This compound is co-crystalized at the ATP-binding site of the AMPK alpha subunit (PDB: 4CFE, 4CFF, 4ZHX, and 5EZV), and its molecular coupling shows a ΔG ≈ – 13.5 ± 1.3 Kcal/mol. Free energy variation of all identified compounds from the Olive-tree leaves AMPK alpha subunit have significantly higher values than staurosporine; therefore, no inhibitory effect on the AMPK catalytic subunit should be expected for these compounds. However, some of these compounds could act as fine regulators of the AMPK alpha subunit and beta subunit.

It has been reported that polyphenols such as p-coumaric, luteolin, and quercetin, in their aglycone form, are able to increase the phosphorylation of AMPK in 3T3-L1 cells [16,31,36,37]. Unlike previous findings, our results also suggest that some of the phenolic compounds from Olive-tree leaves exhibit AMPK activation as glycosides when added to the extracellular media. In agreement with our results, some authors have demonstrated the antiadipogenic effect of luteolin glucoside on 3T3-L1 adipocytes, which might indicate that such phenolic glucosides could either be able to go through the plasmatic membrane [15] or could be metabolized to luteolin aglycone at the intracellular level. The fact that the treatment of adipocytes or hepatocytes with PPAR activators, such as plant polyphenols [26], enhanced glucuronidation activity and UDP-glucuronosyltransferase expression suggests that the glucuronide metabolites of polyphenols may also reach intracellular targets [38]. Surprisingly, other authors have found an adipogenic effect of quercetin (10 μM) on human mesenchymal stem cells [39]. This apparent discrepancy may be attributed to the different experimental model used or even to the different adipogenic induction timing. In any case, the inhibitory capacity of quercetin on adipogenesis is well documented in murine cell and animal model [28,40]. An explanation could be that differentiation into adipocytes may be independent of mitotic clonal expansion depending on the type of cell line.

However, we should express caution when extrapolating cell model data to in vivo conditions. Most glycosylated phenolic compounds are converted into their aglycones on the cell surface of the intestinal epithelial cells and bacteria. Upon absorption, the aglycone forms are subjected to enzymatic modification, and their different metabolites, (glucuronide, sulfated, or methylated metabolites) reach their target tissues and organs [24].

Most of the fractions showing inhibitory activity on AMPK (F6, F8, F16, F17 and F28) behaved as mild inhibitors. Nevertheless, the potent inhibitory effect of fraction 28 (p<0.001), which contains the flavone apigenin among other compounds, should be noted. Although apigenin has been shown to have an antiadipogenic effect through AMPK activation in the adipocyte model [41], the inhibitory effect of this fraction could be due to the inhibition of AMPK reported for some saturated fatty acids also present in this fraction [42]. In relation to the potential inhibitory mechanism, it is known that the phosphorylation of AMPK is reversed by phosphatases, although the exact mechanisms that modulate this action remain poorly understood [43].

Although beyond the scope of the present study, it has been found that the overactivation of AMPK has been observed in several neurodegenerative diseases, such as Alzheimer’s disease, progressive supranuclear palsy, corticobasal degeneration, Pick’s disease, Parkinson’s disease, and others [7]. Therefore, AMPK inhibitors could also be relevant as therapeutic therapies against these types of diseases.

Some secoiridoids from extra virgin olive oil, i.e., oleuropein aglycone and decarboxymethyl oleuropein aglycone, have been demonstrated to activate AMPK, which results in the inhibition of the mammalian target of rapamycin (mTOR) in breast cancer cells [18,27]. It has been postulated that chronic diseases associated with aging, such as cancer or obesity, are driven by the overactivation of the nutrient-sensing mTOR gerogene due to the loss of responsiveness to active AMPK, a suppressor of mTOR. In this manner, some secoiridoids from the Olive-tree may act as gerosuppressors, triggering AMPK activation and exerting a transcriptomic signature that reduces mTOR-driven aging. In agreement with this assumption, our findings support the hypothesis that some secoiridoids from Olea europaea (oleoside/secologanoside, elenolic acid glucoside, demethyloleuropein/demethyloleuroside, oleuropein/oleuroside, oleuropein glucoside and hydroxyoleuropein/ hydroxyoleuroside) may contribute to the activation of AMPK by Olive-tree leaves extract in 3T3-L1 adipocytes, although this should be confirmed using isolated pure compounds in the cell model.

Due to the diverse nature of the natural AMPK activators, one important question arises: how do they manage to activate AMPK despite the fact that their structures are so different? A previous study that used a cell line expressing an AMP- and ADP- insensitive AMPK mutant proposed that phenolic compounds such as quercetin activate AMPK indirectly by increasing cellular AMP and ADP levels, usually by inhibiting mitochondrial ATP synthesis [44]. It has also been reported that oleuropein aglycone indirectly actives AMPK through calcium concentration increases and the subsequent activation of CaMKKβ in SH-SY5Y neuroblastoma cells [19]. Nevertheless, the direct activation of kinases, such as AMPK, by phenolic compounds at the nucleotide binding site has also been proposed [45,46], which is consistent with our results. Whether phenolic compounds exert their AMPK modulation through direct or indirect mechanisms in our cell model should be further confirmed.

Our evidences support that Olive-tree may become a source for bioactive compounds with a potential use in chronic human diseases. Nevertheless, olive-tree leaves composition show a remarkable variability due to location, climate, cultivation practices and seasonal factors. Understanding the factors that control the genetic basis of fruit and leave composition may be necessary for the harvesting and production of suitable extracts to be applied in human health [47,48].


Olive-tree leaves extract decreases intracellular lipid accumulation through AMPK-dependent mechanisms in a hypertrophic and insulin resistant adipocyte model. The fractionation of the extract revealed that fractions containing compounds that belonged to the secoiridoids, cinnamic acids, phenylethanoids and phenylpropanoids, flavonoids and lignans subclasses were the best candidates to account for such effects. Our in silico results suggest the possibility that some of these compounds may be considered putative AMPK ligands or regulators at the three sites of the AMPK gamma subunit. However, the interaction of these compounds with the AMPK alpha subunit binding site or the AMPK beta subunit regulatory binding site is less probable, although a subtle regulation may occur. In conclusion, Olive-tree leaves compounds deserve further attention as a therapeutic aid in the management of obesity and/or its associated disturbances. Nevertheless, further research using pure isolated compounds in cell and animal models and including cell metabolic studies will be required to identify the compounds responsible for such effects.

Supporting information

S1 Fig. Proposed molecular structure of the identified compounds showed on Table 1 for selected fractions with biological activity over AMPK kinase.


S2 Fig. Base Peak Chromatogram (BPC) made by HPLC-ESI-TOF.

This BPC was obtained in negative ion mode of the olive leaf extract, with the optimized semi-preparative conditions, and the collected fractions highlighted in blue.


S3 Fig. AMPK binding sites.

Panels A, C and E show the secondary structure of alpha, beta and gamma subunits of AMPK kinase (4CFE.pdb), respectively. Panels B, D and F represent the electrostatic potential surface with a co-crystalized ligand indicating the position of each binding sites.



This work was supported by the projects BFU2014-52433-C3-2-R, AGL2011-29857-C03-02 (Spanish Ministry of Science and Innovation); projects AGL2015-67995-C3-1-R, AGL2015-67995-C3-2-R, AGL2015-67995-C3-3-R, Torres Quevedo grants PTQ-13-06429 and PTQ-14-07243 and scholarship FPU AP2010-2793 from the Spanish Ministry of Economy and Competitiveness (MINECO); P09-CTS-4564, P10-FQM-6563 and P11-CTS-7625 grants from Andalusian Regional Government Council of Innovation and Science; PROMETEO/2016/006, and ACIF/2016/230 from Generalitat Valenciana; CIBER (CB12/03/30038, Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III).

Author Contributions

  1. Conceptualization: CJS MOV MHL JLS ASC JAE VM.
  2. Data curation: CJS MOV.
  3. Formal analysis: MHL JAE VM.
  4. Funding acquisition: MHL JLS ASC AFG JAE VM.
  5. Investigation: CJS CRP JAE.
  6. Methodology: CJS MOV MHL CRP.
  7. Project administration: MHL ASC AFG JAE VM.
  8. Resources: ASC AFG JAE VM.
  9. Software: MHL JAE.
  10. Supervision: MOV MHL JLS JAE VM.
  11. Validation: ASC MHL JAE VM.
  12. Visualization: CJS MHL MOV JAE.
  13. Writing – original draft: CJS JAE VM.
  14. Writing – review & editing: MHL JLS JAE VM.


  1. 1. Siriwardhana N, Kalupahana NS, Cekanova M, LeMieux M, Greer B, Moustahid—Moussa N. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem. 2013; 24: 613–623. pmid:23498665
  2. 2. Ma S, Jing F, Xu C, Zhou L, Song Y, Yu C, et al. Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3. Sci Rep. 2015; 5: 7633. pmid:25559747
  3. 3. Kalupahana NS, Moustaid-Moussa N, Claycombe KJ. Immunity as a link between obesity and insulin resistance. Mol Aspects Med. 2012; 33: 26–34. pmid:22040698
  4. 4. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem. 2014; 25: 1–18. pmid:24314860
  5. 5. Bijland S, Mancini SJ, Salt IP. Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin Sci (Lond). 2013; 124: 491–507.
  6. 6. Carling D, Thornton C, Woods A, Sanders MJ. AMP-activated protein kinase: new regulation, new roles? Biochem J. 2012; 445: 11–27. pmid:22702974
  7. 7. Novikova DS, Garabadzhiu AV, Melino G, Barlev NA, Tribulovich VG. AMP-activated protein kinase: structure, function, and role in pathological processes. Biochemistry (Mosc). 2015; 80: 127–144.
  8. 8. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, et al. Structure of mammalian AMPK and its regulation by ADP. Nature. 2011; 472: 230–233. pmid:21399626
  9. 9. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA. 2004; 101: 3329–3335. pmid:14985505
  10. 10. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009; 9: 563–575. pmid:19629071
  11. 11. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005; 2: 21–33. pmid:16054096
  12. 12. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J. 2007; 403: 139–148. pmid:17147517
  13. 13. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012; 13: 251–262. pmid:22436748
  14. 14. Ko HJ, Lo CY, Wang BJ, Chiou RYY, Lin SM. Theaflavin-3,3'-digallate, a black tea polyphenol, stimulates lipolysis associated with the induction of mitochondrial uncoupling proteins and AMPK-FoxO3A-MnSOD pathway in 3T3-L1 adipocytes. J Funct Foods. 2015; 17: 271–282.
  15. 15. Kim J, Lee I, Seo J, Jung M, Kim Y, Yim N, et al. Vitexin, orientin and other flavonoids from Spirodela polyrhiza inhibit adipogenesis in 3T3-L1 cells. Phytother Res. 2010; 24: 1543–1548. pmid:20878708
  16. 16. Herranz-Lopez M, Barrajon-Catalan E, Segura-Carretero A, Menendez JA, Joven J, Micol V. Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related disturbances in hypertrophic adipocytes through AMPK-dependent mechanisms. Phytomedicine. 2015; 22: 605–614. pmid:26055125
  17. 17. Joven J, Espinel E, Rull A, Aragones G, Rodriguez-Gallego E, Camps J, et al. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim Biophys Acta. 2012; 1820: 894–899. pmid:22503922
  18. 18. Menendez JA, Joven J, Aragones G, Barrajon-Catalan E, Beltran-Debon R, Borrás-Linares I, et al. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents. Cell Cycle. 2013; 12: 555–578. pmid:23370395
  19. 19. Rigacci S, Miceli C, Nediani C, Berti A, Cascella R, Pantano D, et al. Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight. Oncotarget. 2015; 6: 35344–35357. pmid:26474288
  20. 20. Talhaoui N, Gomez-Caravaca AM, Leon L, De la Rosa R, Segura-Carretero A, Fernández-Gutiérrez A. Determination of phenolic compounds of 'Sikitita' olive leaves by HPLC-DAD-TOF-MS. Comparison with its parents 'Arbequina' and 'Picual' olive leaves. LWT—Food Sci Technol. 2014; 58: 28–34.
  21. 21. Quirantes-Pine R, Lozano-Sanchez J, Herrero M, Ibanez E, Segura-Carretero A, Fernández-Gutiérrez A. HPLC-ESI-QTOF-MS as a Powerful Analytical Tool for Characterising Phenolic Compounds in Olive-leaf Extracts. Phytochem Anal. 2013; 24: 213–223. pmid:22987739
  22. 22. Lozano-Sanchez J, Segura-Carretero A, Menendez JA, Oliveras-Ferraros C, Cerretani L, Fernández-Gutiérrez A. Prediction of extra virgin olive oil varieties through their phenolic profile. Potential cytotoxic activity against human breast cancer cells. J Agric Food Chem. 2010; 58: 9942–9955. pmid:20795736
  23. 23. Green H, Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 1975; 5: 19–27. pmid:165899
  24. 24. Herranz-Lopez M, Fernandez-Arroyo S, Perez-Sanchez A, Barrajon-Catalan E, Beltran-Debon R, Menéndez JA, et al. Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine. 2012; 19: 253–261. pmid:22280831
  25. 25. Feoktistova M, Geserick P, Leverkus M. Crystal Violet Assay for Determining Viability of Cultured Cells. Cold Spring Harb Protoc. 2016;
  26. 26. Encinar JA, Fernandez-Ballester G, Galiano-Ibarra V, Micol V. In silico approach for the discovery of new PPARgamma modulators among plant-derived polyphenols. Drug Des Devel Ther. 2015; 9: 5877–5895. pmid:26604687
  27. 27. Barrajon-Catalan E, Herranz-Lopez M, Joven J, Segura-Carretero A, Alonso-Villaverde C, Menéndez JA, et al. Molecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties. Adv Exp Med Biol. 2014; 824: 141–159. pmid:25038998
  28. 28. Moon J, Do HJ, Kim OY, Shin MJ. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food and Chem Toxicol. 2013; 58: 347–354.
  29. 29. Sung J, Lee J. Capsicoside G, a furostanol saponin from pepper (Capsicum annuum L.) seeds, suppresses adipogenesis through activation of AMP-activated protein kinase in 3T3-L1 cells. J Funct Foods. 2016; 20: 148–158.
  30. 30. Gonzalez-Barroso MM, Anedda A, Gallardo-Vara E, Redondo-Horcajo M, Rodriguez-Sanchez L, Rial E. Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial beta-oxidation. Biochim Biophys Acta. 2012; 1817: 1768–1775. pmid:22386881
  31. 31. Kang SI, Shin HS, Kim HM, Hong YS, Yoon SA, Kang SW, et al. Immature Citrus sunki peel extract exhibits antiobesity effects by beta-oxidation and lipolysis in high-fat diet-induced obese mice. Biol Pharm Bull. 2012; 35: 223–230. pmid:22293353
  32. 32. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011; 13: 376–388. pmid:21459323
  33. 33. Yuan HD, Piao GC. An active part of Artemisia sacrorum Ledeb. inhibits adipogenesis via the AMPK signaling pathway in 3T3-L1 adipocytes. Int J Mol Med. 2011; 27: 531–536. pmid:21327327
  34. 34. Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 2006; 3: 403–416. pmid:16753576
  35. 35. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, et al. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem. 2007; 282: 32549–32560. pmid:17855357
  36. 36. Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J. 2005; 386: 471–478. pmid:15469417
  37. 37. Xiao N, Mei F, Sun Y, Pan G, Liu B, Liu K. Quercetin, luteolin, and epigallocatechin gallate promote glucose disposal in adipocytes with regulation of AMP-activated kinase and/or sirtuin 1 activity. Planta Med. 2014; 80: 993–1000. pmid:25057854
  38. 38. Barbier O, Villeneuve L, Bocher V, Fontaine C, Torra IP, Duhem C, et al. The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J Biol Chem. 2003; 278: 13975–13983. pmid:12582161
  39. 39. Casado-Diaz A, Anter J, Dorado G, Quesada-Gomez JM. Effects of quercetin, a natural phenolic compound, in the differentiation of human mesenchymal stem cells (MSC) into adipocytes and osteoblasts. J Nutr Biochem. 2016; 32: 151–162. pmid:27142748
  40. 40. Seo MJ, Lee YJ, Hwang JH, Kim KJ, Lee BY. The inhibitory effects of quercetin on obesity and obesity-induced inflammation by regulation of MAPK signaling. J Nutr Biochem. 2015; 26: 1308–1316. pmid:26277481
  41. 41. Ono M, Fujimori K. Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells. J Agric Food Chem. 2011; 59: 13346–13352. pmid:22098587
  42. 42. Kwon B, Querfurth HW. Palmitate activates mTOR/p70S6K through AMPK inhibition and hypophosphorylation of raptor in skeletal muscle cells: Reversal by oleate is similar to metformin. Biochimie. 2015; 118: 141–150. pmid:26344902
  43. 43. Russo GL, Russo M, Ungaro P. AMP-activated protein kinase: a target for old drugs against diabetes and cancer. Biochem Pharmacol. 2013; 86: 339–350. pmid:23747347
  44. 44. Hawley SA, Ross FA, Chevtzoff C, Green KA, Evans A, Fogarty S, et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 2010; 11: 554–565. pmid:20519126
  45. 45. Corominas-Faja B, Santangelo E, Cuyas E, Micol V, Joven J, Ariza X, et al. Computer-aided discovery of biological activity spectra for anti-aging and anti-cancer olive oil oleuropeins. Aging (Albany NY). 2014; 6: 731–741.
  46. 46. Taha MO, Khanfar MA. Oleuropein potently inhibits mammalian target of rapamycin: possible involvement of tandem anomeric hyperconjugation-Michael reaction. Med Chem Res. 2015; 24: 616–623.
  47. 47. Dundar E, Suakar O, Unver T, Dagdelen A. Isolation and expression analysis of cDNAs that are associated with alternate bearing in Olea europaea L. cv. Ayvalik. BMC Genomics. 2013; 14: 219. pmid:23552171
  48. 48. Yanik H, Turktas M, Dundar E, Hernandez P, Dorado G, Unver T. Genome-wide identification of alternate bearing-associated microRNAs (miRNAs) in olive (Olea europaea L.). BMC Plant Biol 2013; 13: 10. pmid:23320600
  49. 49. Guinda A, Castellano JM, Santos-Lozano JM, Delgado-Hervas T, Gutierrez-Adanez P, Rada M. Determination of major bioactive compounds from olive leaf. LWT—Food Sci Technol. 2015; 64: 431–438.
  50. 50. Peralbo-Molina A, Priego-Capote F, Luque de Castro MD. Tentative identification of phenolic compounds in olive pomace extracts using liquid chromatography-tandem mass spectrometry with a quadrupole-quadrupole-time-of-flight mass detector. J Agric Food Chem. 2012; 60: 11542–11550. pmid:23106267
  51. 51. Toth G, Alberti A, Solyomvary A, Barabas C, Boldizsar I, Noszal B. Phenolic profiling of various olive bark-types and leaves: HPLC-ESI/MS study. Ind Crops Prod. 2015; 67: 432–438.
  52. 52. Fu S, Arraez-Roman D, Segura-Carretero A, Menendez JA, Menendez-Gutierrez MP, MIcol V, et al. Qualitative screening of phenolic compounds in olive leaf extracts by hyphenated liquid chromatography and preliminary evaluation of cytotoxic activity against human breast cancer cells. Anal Bioanal Chem. 2010; 397: 643–654. pmid:20238105
  53. 53. Michel T, Khlif I, Kanakis P, Termentzi A, Allouche N, Halabalaki M, et al. UHPLC-DAD-FLD and UHPLC-HRMS/MS based metabolic profiling and characterization of different Olea europaea organs of Koroneiki and Chetoui varieties. Phytochem Lett. 2015; 11: 424–439.
  54. 54. Talhaoui N, Gomez-Caravaca AM, Roldan C, Leon L, De la Rosa R, Fernández-Gutiérrez A, et al. Chemometric Analysis for the Evaluation of Phenolic Patterns in Olive Leaves from Six Cultivars at Different Growth Stages. J Agric Food Chem. 2015; 63: 1722–1729. pmid:25613562
  55. 55. Borja R, Martin A, Maestro R, Alba J, Fiestas JA. Enhancement of the anaerobic-digestion of olive mill waste-water by the removal of phenolic inhibitors. Process Biochem. 1992; 27: 231–237.
  56. 56. She GM, Wang D, Zeng SF, Yang CR, Zhang YJ. New phenylethanoid glycosides and sugar esters from ku-ding-cha, a herbal tea produced from Ligustrum purpurascens. J Food Sci. 2008; 73: C476–481. pmid:19241537
  57. 57. Saimaru H, Orihara Y. Biosynthesis of acteoside in cultured cells of Olea europaea. J Nat Med. 2010; 64: 139–145. pmid:20037799
  58. 58. Taamalli A, Arraez-Roman D, Ibanez E, Zarrouk M, Segura-Carretero A, Fernández-Gutiérrez A. Optimization of microwave-assisted extraction for the characterization of olive leaf phenolic compounds by using HPLC-ESI-TOF-MS/IT-MS2. J Agric Food Chem. 2012; 60: 791–798. pmid:22206342
  59. 59. Klen TJ, Wondra AG, Vrhovsek U, Vodopivec BM. Phenolic Profiling of Olives and Olive Oil Process-Derived Matrices Using UPLC-DAD-ESI-QTOF-HRMS Analysis. J Agric Food Chem. 2015; 63: 3859–3872. pmid:25782340
  60. 60. Hosny M, Ragab E, Mohammed A, Shaheen U. New secoiridoids from Ligustrum ovalifolium and their hypotensive activity. Pharmacognosy Res. 2009; 1: 91–97.
  61. 61. Perez-Bonilla M, Salido S, van Beek TA, de Waard P, Linares-Palomino PJ, Sánchez A, et al. Isolation of antioxidative secoiridoids from olive wood (Olea europaea L.) guided by on-line HPLC-DAD-radical scavenging detection. Food Chem. 2011; 124: 36–41.
  62. 62. Goodger JQ, Cao B, Jayadi I, Williams SJ, Woodrow IE. Non-volatile components of the essential oil secretory cavities of Eucalyptus leaves: discovery of two glucose monoterpene esters, cuniloside B and froggattiside A. Phytochemistry. 2009; 70: 1187–1194. pmid:19604527
  63. 63. Meakins GD, Swindells R. The structures of two acids from olive leaves. J Chem Soc. 1959: 1044–1047.
  64. 64. Melguizo-Melguizo D, Diaz-de-Cerio E, Quirantes-Pine R, Svarc-Gajic J, Segura-Carretero A The potential of Artemisia vulgaris leaves as a source of antioxidant phenolic compounds. J Funct Foods. 2014; 10: 192–200.